Springer Health+ IME
@SpringerIME
Springer Health+ IME, providing independent medical education in Neurology, Diabetes, Oncology, Rare Diseases, Endocrinology, and Paediatrics.
2.8K Following 19.8K Followers
Are you exploring how to set up an amyloidosis center in Latin America? Join our roundtable virtual meeting for region-specific insights from experts who have established a successful center.
Are you exploring how to set up an amyloidosis center in Latin America? Join our virtual roundtable meeting to discuss country‑specific challenges, exchange insights, and begin building a supportive professional network.
Show more
Explore the clinical data supporting available and emerging treatment options for NTRK fusion-positive NSCLC with this free, downloadable case study—ready to use in your clinical practice.
Are rare fusions still off your radar in NSCLC?
Download this free, print-ready case study, exploring the clinical data supporting available and emerging treatments for NTRK fusion-positive NSCLC.
Get best practices for identifying rare fusions in NSCLC with this free, downloadable case study—ready to use in your clinical practice.
How confident are you that you'd catch an NTRK fusion in NSCLC?
Download this free, print-ready case study, covering best practices for biomarker testing to identify NTRK fusions.
Breaking from EASL 2026: Observational data show IBAT inhibitor promise for pruritus in late-onset PFIC and ICP.
Live from EASL 2026: Intrahepatic cholestasis of pregnancy recurs in 4 in 10 pregnancies.
Dr Jeremy Nayagam speaks live from EASL 2026, highlighting research on genetic testing in adults with unexplained cholestatic liver disease and hepatitis.
Watch the full video now, and explore our coverage of the congress.
Show more
Breaking from EASL 2026: Genetic variants explain substantial proportion of undiagnosed cholestasis and hepatitis.
Live from EASL 2026: Researchers call for ICP to be included in hepatobiliary risk stratification.
From emerging therapies to tactics for multidisciplinary collaboration, this free, CME-accredited video podcast series combines expert insights with the latest scientific data to increase your clinical confidence in the management of generalized myasthenia gravis.
Show more
Explore emerging therapeutic approaches to the management of generalized myasthenia gravis in this free, CME-accredited video podcast series, led by Dr. Kelly Gwathmey.
Are you up to date with the latest scientific insights into generalized myasthenia gravis (gMG)? Optimize your gMG care strategy using our free, CME-accredited video podcast series, led by Dr. Kelly Gwathmey.
Show more
From emerging therapies to tactics for multidisciplinary collaboration, this free, CME accredited video podcast series combines expert insights with the latest scientific data to help clinicians deliver a patient-focused generalized myasthenia gravis care strategy.
Show more
Unpick the latest clinical breakthroughs, emerging data, and practical insights in the management of generalized myasthenia gravis with our free, CME-accredited video podcast series, led by Dr. Kelly Gwathmey.
Show more
New phase 2 trial findings published in The Lancet Diabetes & Endocrinology suggest burosumab treatment for X-linked hypophosphataemia (XLH) may begin in the first year of life. Unpick the findings in our latest article.
Show more
Basket trial findings indicate that vosoritide therapy may improve growth in children with short stature related to rare genetic disorders of the Ras–mitogen-active protein kinase (MAPK) pathway. Read the full article now.
Show more
